small - 医索

BEAT-SC A randomized phase lll study ofbevacizumab or placebo in combination withatezolizumab and platinum-based chemotherapy inpatients with extensive-stage small cell lung cancer

医客学院 - 会议报告集

Amivantamab plus lazertinib vs osimertinib infirst-line EGFR-mutant advanced non-small cell lungcancer(NSCLC)with biomarkers of high-risk diseaseA secondary analysis from the phase 3 MARIPOSA study

医客学院 - 会议报告集

Amivantamab plus lazertinib in atypical EGFR-mutatedadvanced non-small cell lung cancer (NSCLC)Results from CHRYSALIS-2

医客学院 - 会议报告集

Adjuvant icotinib of 12 months or 6 months versus observationfollowing adjuvant chemotherapy for resected EGFR-mutatedstage ll-lllA non-small-cell lung cancer (ICTAN, GASTO1002) arandomized phase 3 trial

医客学院 - 会议报告集

A Phase ll Randomized Trial Evaluating ConsolidativeNivolumab in Locally Advanced Non-Small Cell LungCancer Post Neoadjuvant Nivolumab plus Chemotherapyand Concurrent chemoradiotherapy (CA209-7AL)

医客学院 - 会议报告集

A Multinational Pivotal Study of Sunvozertinib inPlatinum Pre-treated Non-Small Cell Lung Cancerwith EGFR Exon 20 Insertion MutationsPrimary Analysis of WU-KONG1 Study

医客学院 - 会议报告集

中医科学院青蒿素研究所最新成果：传统中药发酵冬虫夏草菌粉联合PD1抗肿瘤疗效如何？

导读2024年3月，由中国中医科学院青蒿素研究中心和西南医科大学附属医院肿瘤科团队共同合作的一项题为“Cordyceps sinensis relieves non-small cell lung cancer byinhibiting theMAPK pathway”的研究成果发表于SCI期刊 Chine.....

学术资讯 - 免疫基础

Alectinib in Resected ALK -Positive Non–Small-Cell Lung Cancer

医客学院 - 其他

Therapy for Stage IV Non–Small Cell Lung Cancer With Driver Alterations ASCO Living Guideline, Version 2023.3

医客学院 - 指南共识

SMALL CELLLUNG CANCER -CURRENT STANDARD AND FUTURE OPPORTUNITIES（KAUSHAL）

医客学院 - 会议报告集